LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

Search

Astrana Health Inc

Gesloten

SectorGezondheidszorg

23.02 -0.86

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

22.9

Max

23.24

Belangrijke statistieken

By Trading Economics

Inkomsten

-9.8M

373K

Verkoop

301M

956M

K/W

Sectorgemiddelde

118.947

79.874

Winstmarge

0.039

Werknemers

1,900

EBITDA

7.9M

39M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+46.42% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-389M

1.1B

Vorige openingsprijs

23.88

Vorige sluitingsprijs

23.02

Nieuwssentiment

By Acuity

75%

25%

349 / 374 Rangschikking in Healthcare

Astrana Health Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

27 nov 2025, 16:49 UTC

Acquisities, Fusies, Overnames

Deutsche Boerse in Talks to Buy Fund-Tech Platform Allfunds in $6 Billion Deal

27 nov 2025, 15:32 UTC

Acquisities, Fusies, Overnames

TotalEnergies, Repsol in Talks to Combine U.K. North Sea Assets, Cinco Dias Says, Citing Sources

27 nov 2025, 23:50 UTC

Marktinformatie

Nikkei May Trade Rangebound Amid Caution Over Economic Outlook -- Market Talk

27 nov 2025, 23:50 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

27 nov 2025, 16:05 UTC

Marktinformatie

Canadian Job Vacancies Rise for Fist Time Since Start of 2024 -- Market Talk

27 nov 2025, 16:04 UTC

Marktinformatie

Canadian Payroll Employment Pulls Back in September, Offsetting Recent Gains -- Market Talk

27 nov 2025, 15:54 UTC

Acquisities, Fusies, Overnames

Allfunds Shares Rise 21% After Deutsche Boerse Says Started Acquisition Talks

27 nov 2025, 15:44 UTC

Acquisities, Fusies, Overnames

Deutsche Boerse: No Certainty Talks Will Result in Transaction

27 nov 2025, 15:43 UTC

Acquisities, Fusies, Overnames

Deutsche Boerse: Allfunds Board of Directors Has Agreed to Enter Exclusive Talks

27 nov 2025, 15:42 UTC

Acquisities, Fusies, Overnames

Deutsche Boerse: Nonbinding Proposal is To Acquire Allfunds at EUR8.80 a Share

27 nov 2025, 15:41 UTC

Acquisities, Fusies, Overnames

Deutsche Boerse in Talks With Allfunds on Possible Acquisition

27 nov 2025, 15:11 UTC

Marktinformatie

Dollar Could Fall in 2026 as U.S. Rate Cuts Bite -- Market Talk

27 nov 2025, 14:26 UTC

Marktinformatie

Hermes' Outperformance Gap Could Narrow -- Market Talk

27 nov 2025, 14:11 UTC

Marktinformatie

Lack of Major Budget Surprises Don't Justify Continued Sterling Strength -- Market Talk

27 nov 2025, 14:11 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

27 nov 2025, 13:35 UTC

Marktinformatie

Richemont Looks Set to Continue Outgrowing Peers -- Market Talk

27 nov 2025, 13:33 UTC

Marktinformatie

Sterling's Post-Budget Gains Are Probably Over -- Market Talk

27 nov 2025, 13:22 UTC

Marktinformatie

Global Equities Roundup: Market Talk

27 nov 2025, 13:22 UTC

Marktinformatie

Kering's Plan to Revive Gucci Needs More Clarity -- Market Talk

27 nov 2025, 13:17 UTC

Marktinformatie

LVMH Should Be Able to Recover Next Year -- Market Talk

27 nov 2025, 11:13 UTC

Marktinformatie

European Gas Prices Come Under Pressure -- Market Talk

27 nov 2025, 11:07 UTC

Winsten

Genting: Positive About Prospects Over Longer Term

27 nov 2025, 11:06 UTC

Winsten

Genting: Cautious on Near-Term Prospects of Leisure, Hospitality Industry

27 nov 2025, 11:04 UTC

Winsten

Genting: International Travel Demand Expected to Remain Resilient

27 nov 2025, 11:04 UTC

Winsten

Genting: Global Growth Expected to Remain Subdued

27 nov 2025, 11:04 UTC

Winsten

Genting: Ebitda Partly Weighed by Stronger Ringgit Vs. Singapore Dollar, British Pound, U.S. Dollar

27 nov 2025, 10:59 UTC

Winsten

Genting Bhd 3Q Net Profit Fell 86% on Year

27 nov 2025, 10:58 UTC

Winsten

Genting Bhd 3Q Rev Rose 14% on Year

27 nov 2025, 10:56 UTC

Winsten

Genting Bhd 3Q Net MYR30.3M

27 nov 2025, 10:56 UTC

Winsten

Genting Bhd 3Q EPS MYR0.0079

Peer Vergelijking

Prijswijziging

Astrana Health Inc Prognose

Koersdoel

By TipRanks

46.42% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 33.75 USD  46.42%

Hoogste 37 USD

Laagste 26 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor Astrana Health Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

7 ratings

5

Buy

2

Hold

0

Sell

Sentiment

By Acuity

349 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Astrana Health Inc

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
help-icon Live chat